SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

$60M

Amount

Series B

Stage

03.08.2023

Date

3

all rounds

$170M

Total amount

date founded

Financing round

General

About Company
Kyverna Therapeutics is a company that is developing new therapies and cures for serious autoimmune diseases.

Industry

Sector :

Subsector :

founded date

01.01.2018

founders

Number of employees

11-50

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Their cell-based therapeutics use advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells that cause inflammatory diseases, providing relief to patients suffering from autoimmune diseases. Kyverna is at the forefront of a new class of treatments for these debilitating conditions.
Contacts

location

Berkeley, CA, USA

Contact Email

Website URL

http://kyvernatx.com/

Social url

Similar Companies
1000
Rubius Therapeutics
Rubius TherapeuticsRubius Therapeutics develops Red-Cell Therapeutics to treat rare diseases, cancer, and autoimmune diseases.
Rubius Therapeutics

Rubius Therapeutics

Rubius Therapeutics develops Red-Cell Therapeutics to treat rare diseases, cancer, and autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

4

total raised

$445M
Atara Biotherapeutics
Atara BiotherapeuticsAtara Biotherapeutics is developing transformative off-the-shelf therapies for serious diseases.
Atara Biotherapeutics

Atara Biotherapeutics

Atara Biotherapeutics is developing transformative off-the-shelf therapies for serious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

South San Francisco, CA, USA

total rounds

9

total raised

$499.82M
Abata Therapeutics
Abata TherapeuticsAbata Therapeutics develops cell therapy to treat autoimmune and inflammatory diseases.
Abata Therapeutics

Abata Therapeutics

Abata Therapeutics develops cell therapy to treat autoimmune and inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Cambridge, MA, USA

total rounds

1

total raised

$95M
Pandion Therapeutics
Pandion TherapeuticsPandion Therapeutics develops novel therapeutics for autoimmune diseases.
Pandion Therapeutics

Pandion Therapeutics

Pandion Therapeutics develops novel therapeutics for autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Cambridge, MA, USA

total rounds

2

total raised

$138M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$170M

Money Raised

Their latest funding was raised on 03.08.2023. Their latest investor RTW Investments LLC. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
03.08.2023
Series B
10
$60M
—
26.01.2022
Series B
13
$85M
Northpond Ventures
Northpond Ventures
13.01.2020
Series A
2
$25M
—
Northpond Ventures

Northpond Ventures

Northpond Ventures is a science-driven venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bethesda, MD, USA

count Of Investments

111

count Of Exists

4
Co-Investors
Investors
14
1

Number of lead investors

14

Number of investors

Investor 
Lead 
Round 
Partners 
RTW Investments LLC
RTW Investments LLC
No
Series B
Chris Liu
GordonMD Global Investments
GordonMD Global Investments
No
Series B
—
Gilead Sciences
Gilead Sciences
No
Series B
—
RTW Investments LLC

RTW Investments LLC

RTW Investments is an innovative health care investment firm.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Health Care

Location

New York, NY, USA

count Of Investments

86

count Of Exists

3

Chris Liu

Chris Liu is a Senior Analyst at RTW Investments, LP.

GordonMD Global Investments

GordonMD Global Investments

GordonMD Global Investments is a private equity firm that invests in innovative biopharma companies worldwide.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital

Location

Beverly Hills, CA, USA

count Of Investments

9
Gilead Sciences

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and commercializes innovative medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Biopharma

Location

Foster City, CA, USA

total rounds

4

total raised

$4.41B

count Of Investments

44

count Of Exists

1

People

Founders
1
Jeffrey Greve
Jeffrey Greve

Jeffrey Greve

Jeffrey Greve is the Chief Scientific Officer and Founder at Kyverna Therapeutics. He attended The Johns Hopkins University.

current job

Kyverna Therapeutics
Kyverna Therapeutics

organization founded

2
Jeffrey Greve

Jeffrey Greve

Employee Profiles
5
Tom Van Blarcom
Tom Van Blarcom

Tom Van Blarcom

Senior Vice President, Head of Research

Senior Vice President, Head of Research

Karen Walker
Karen Walker

Karen Walker

Chief Technical Officer

Chief Technical Officer

Jeffrey Greve
Jeffrey Greve

Jeffrey Greve

Co-Founder and Chief Scientific Officer

Co-Founder and Chief Scientific Officer

Dominic Borie
Dominic Borie

Dominic Borie

CEO

CEO

Christine Geary
Christine Geary

Christine Geary

Sr Talent Acquisition Consultant

Sr Talent Acquisition Consultant

Activity

Recent News
25
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week